2018
DOI: 10.3390/ijms19082362
|View full text |Cite
|
Sign up to set email alerts
|

Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer

Abstract: The past few decades have witnessed widespread research to challenge carcinogenesis; however, it remains one of the most important health concerns with the worst prognosis and diagnosis. Increasing lines of evidence clearly show that the rate of cancer incidence will increase in future and will create global havoc, designating it as an epidemic. Conventional chemotherapeutics and treatment with synthetic disciplines are often associated with adverse side effects and development of chemoresistance. Thus, discov… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
84
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 128 publications
(86 citation statements)
references
References 151 publications
1
84
0
1
Order By: Relevance
“…Despite in vitro findings showing the anti-proliferative and anti-invasive effects of Hono and Mag, changes in in vivo bioluminescence imaging were too subtle to detect among all groups. The potency of Hono and Mag as adjuvants for chemotherapy has been established in the literature (Arora et al, 2012;Ranaware et al, 2018). As a result, one plausible explanation for our in vivo data could be the absence of common chemotherapeutic agents.…”
Section: Discussionsupporting
confidence: 55%
“…Despite in vitro findings showing the anti-proliferative and anti-invasive effects of Hono and Mag, changes in in vivo bioluminescence imaging were too subtle to detect among all groups. The potency of Hono and Mag as adjuvants for chemotherapy has been established in the literature (Arora et al, 2012;Ranaware et al, 2018). As a result, one plausible explanation for our in vivo data could be the absence of common chemotherapeutic agents.…”
Section: Discussionsupporting
confidence: 55%
“…Tumorigenic cells can lead to the deregulation of multiple signaling pathways. Hence, compounds that act on multiple targets are required in the deterrence and treatment of cancer malignancies [39][40][41][42]. Various studies show the consecutive activation of major signaling pathways which leads to activation of downstream proteins, and contributes to survival, angiogenesis, and metastasis of cancer cells (illustrated in Figure 2).…”
Section: Molecular Targets Of Ramentioning
confidence: 99%
“…Cancer is the second-most common cause of death globally, responsible for 9.6 million fatalities in 2018 alone, i.e., one in six deaths, globally [1][2][3][4][5][6]. Approximately 17 million people are diagnosed with cancer every year, of which, 70% of deaths occur in lower-middle-and lower-class income families [1].…”
Section: Introductionmentioning
confidence: 99%